Biotron shareholders

This website is to keep Biotron shareholders informed as to what is happening with the company and, in particular, what happened with the proposed change of management.

Biotron was established about 25 years ago, with very promising prospects, and shares valued at $0.50.

Since then, the company has not entered into any commercial arrangements which have generated any money, and almost all the funding has come from government grants and shareholders buying further shares and rights. The company has so far spent over $60 million with no commercial benefit to date. Despite this poor performance, the directors have continued to pay themselves handsomely with with CEO Michelle Miller receiving receiving around $380,000 per year and the chairman Michael Hoy receiving receiving around $8000 per month.

During June 2025, Tim Somerville (who conducts this website) asked shareholders to complete a survey . The responses from the survey were overwhelmingly in favour of the suggestion of the restructure of the Board of Directors. In accordance with those responses, a shareholders advisory committee was formed, and proposed new directors were nominated, from amongst the shareholders holding most shares.

Also, in accordance with those responses from shareholders, steps were taken to call an Extraordinary General meeting (EGM) to restructure the Board of Directors. The incumbent directors did everything they could to avoid the requirement to call an EGM. However, eventually, they had to call an annual general meeting (AGM) at which motions were put to restructure the board, including appointing new directors.

Tim Somerville, called for proxies to support the change of directors. He received proxies from the holders of over 144,000,000 shares,far more than enough to pass resolutions to restructure the board, including appointing new directors. However, 26 days before the AGM, the directors issued around 200 million shares to unnamed “sophisticated investors”. Their proxies opposed the proxies from the shareholders to Tim Somerville, and all of the motions to restructure the board were defeated.

Please click here for more details  about the Annual General Meeting.

The fight is not over. Please click here for further developments as they occur.

Note. For convenience and to save expense, this website is hosted on the website of Somerville Legal, solicitors. However, Somerville Legal has no involvement in Biotron, and Timothy Somerville no longer has any financial interest in Somerville Legal.